HHLR ADVISORS, LTD. - LEGEND BIOTECH CORP ownership

LEGEND BIOTECH CORP's ticker is LEGN and the CUSIP is 52490G102. A total of 201 filers reported holding LEGEND BIOTECH CORP in Q3 2023. The put-call ratio across all filers is 1.35 and the average weighting 0.5%.

Quarter-by-quarter ownership
HHLR ADVISORS, LTD. ownership history of LEGEND BIOTECH CORP
ValueSharesWeighting
Q3 2023$432,341,922
-2.7%
6,436,5330.0%9.65%
+2.0%
Q2 2023$444,313,873
+79.6%
6,436,533
+25.5%
9.46%
+115.7%
Q1 2023$247,386,297
-3.5%
5,130,367
-0.1%
4.39%
-19.0%
Q4 2022$256,419,921
+22.4%
5,136,6170.0%5.41%
-1.8%
Q3 2022$209,574,000
-14.1%
5,136,617
+15.8%
5.51%
+5.4%
Q2 2022$244,014,000
-3.2%
4,436,617
-36.0%
5.23%
-0.6%
Q1 2022$252,077,000
-54.2%
6,936,617
-41.2%
5.26%
-38.1%
Q4 2021$550,228,000
-1.6%
11,804,925
+6.8%
8.50%
+16.3%
Q3 2021$558,937,000
+1994.7%
11,054,925
+1600.8%
7.31%
+2558.2%
Q2 2021$26,683,000
+41.5%
650,0000.0%0.28%
+47.8%
Q1 2021$18,863,000
+3.1%
650,0000.0%0.19%
+27.4%
Q4 2020$18,304,000
-8.8%
650,0000.0%0.15%
-3.9%
Q3 2020$20,066,000
-27.5%
650,0000.0%0.15%
-39.9%
Q2 2020$27,664,000650,0000.25%
Other shareholders
LEGEND BIOTECH CORP shareholders Q3 2023
NameSharesValueWeighting ↓
FengHe Fund Management Pte. Ltd. 526,072$21,595,00011.36%
Consonance Capital Management LP 1,647,497$67,630,0008.14%
Johnson & Johnson Innovation - JJDC, Inc. 1,629,173$66,878,0006.84%
MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC 1,342,442$55,107,0002.29%
Vivo Capital, LLC 956,702$39,273,0001.70%
Hudson Bay Capital Management LP 1,878,374$77,107,0000.93%
Capital International Sarl 220,470$9,050,0000.78%
Capital International, Inc./CA/ 1,951,845$80,123,0000.72%
Avidity Partners Management LP 625,000$25,656,0000.69%
INDUS CAPITAL PARTNERS, LLC 94,678$3,887,0000.66%
View complete list of LEGEND BIOTECH CORP shareholders